clinical trial · NCT07123727
A Study to Examine Anktiva for the Treatment of COVID-19.
Long COVIDLong COVID SyndromeLong Covid 19Anktiva
brief summary
This study will examine the safety and effectiveness of Anktiva in treating patients with Long COVID-19 which is defined as persistent symptoms of a COVID-19 infection that remain after the infection is over.
started
Sep 4, 2025
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Oct 21, 2025
official title
Single Arm Study to Evaluate the Safety of Nogapendekin Alfa Inbakicept (NAI) in Participants With Long COVID
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol